Evidence map›Paper›PMID 32233081›Full record

Observational studyCancer medicine2020

Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.

Clara Breidenbach, Rebecca Roth, Lena Ansmann, Simone Wesselmann, Sebastian Dieng, Ernst-Günther Carl, Günter Feick, Alisa Oesterle, Peter Bach, Burkhard Beyer and 7 more

Abstract readObservational Study
In one paragraph

Observational study in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Predictors for the utilization of social service counseling by prostate cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Observational
  5. 'Palliative medicine · 2021
    Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Clara BreidenbachGerman Cancer Society, Berlin, Germany.ORCID 0000-0002-1357-472X
Rebecca RothInstitute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine, University of Cologne, Koln, Germany.
Lena AnsmannOrganizational Health Services Research, Department for Health Services Research, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Simone WesselmannGerman Cancer Society, Berlin, Germany.
Sebastian DiengOnkoZert GmbH, Neu-Ulm, Germany.
Ernst-Günther CarlFederal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany.
Günter FeickFederal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany.
Alisa OesterleOnkoZert GmbH, Neu-Ulm, Germany.
Peter BachKliniken Rhein-Ruhr, Herne, Germany.
Burkhard BeyerMartini-Klinik Prostate Cancer Center Hamburg, Hamburg, Germany.
Rainer BorowitzKlinikum Memmingen, Memmingen, Germany.
Jörg ErdmannCaritas-Krankenhaus, Bad Mergentheim, Germany.
Frank KunathUniversity Hospital Erlangen, Erlangen, Germany.
Simba-Joshua OostdamKRH Klinikum Siloah, Hannover, Germany.
Igor TsaurUniversity Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Friedemann ZengerlingUniversity Hospital Ulm, Ulm, Germany.
Christoph KowalskiGerman Cancer Society, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer patients often suffer from psychological distress. Psycho-oncological services (POS) have been established in some health care systems in order to address such issues. This study aims to identify patient and center characteristics that elucidate the use of POS by patients in prostate cancer centers (PCCs).

methodsCenter-reported certification and patient survey data from 3094 patients in 44 certified PCCs in Germany were gathered in the observational study (Prostate Cancer Outcomes). A multilevel analysis was conducted.

resultsModel 1 showed that utilization of POS in PCCs is associated with patients' age (OR = 0.98; 95%-CI = 0.96-0.99; P < .001), number of comorbidities (1-2 vs 0, OR = 1.27; 95%-CI = 1.00-1.60; P=.048), disease staging (localized high-risk vs localized intermediate risk, OR = 1.41; 95%-CI = 1.14-1.74; P < .001), receiving androgen deprivation therapy before study inclusion (OR = 0.19; 95%-CI = 0.10-0.34; P < .001), and hospital teaching status (university vs academic, OR = 0.09; 95%-CI = 0.02-0.55; P = .009). Model 2 additionally includes information on treatment after study inclusion and shows that after inclusion, patients who receive primary radiotherapy (OR = 0.05; 95%-CI = 0.03-0.10; P < .001) or undergo active surveillance/watchful waiting (OR = 0.06; 95%-CI = 0.02-0.15; P < .001) are less likely to utilize POS than patients who undergo radical prostatectomy. Disease staging (localized high-risk vs localized intermediate risk, OR = 1.31; 95%-CI = 1.05-1.62; P = .02) and teaching status (university vs academic, OR = 0.08; 95%-CI = 0.01-0.65; P = .02) are also significant predictors for POS use. The second model did not identify any other significant patient characteristics.

conclusionsFuture research should explore the role of institutional teaching status and whether associations with therapy after study inclusion are due to treatment effects - for example, less need following radiotherapy - or because access to POS is more difficult for those receiving radiotherapy.

Indexed as

Psychosocial Support SystemsAdultAgedAged, 80 and overAndrogen AntagonistsCombined Modality TherapyFollow-Up StudiesHumansMaleMiddle AgedMultilevel AnalysisPrognosisProspective StudiesProstatectomyProstatic NeoplasmsPsycho-OncologyAndrogen Antagonistshealth services researchmultilevel analysisprostate cancerprostate neoplasmspsycho-oncologypsychosocial oncology

Identifiers

PMID32233081
PMCPMC7286449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.